Medicinal significance of nitroimidazoles - Some recent advances

Journal of Scientific and Industrial Research

Volumn 62, Issue 7, 2003, Pages 659-665

  Kapoor, V K ^a   Chadha, Renu ^a   Venisetty, Praveen K ^a   Prasanth, S ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Biological activities; Nitroimidazoles; Therapeutic uses of nitroimidazoles

Indexed keywords

MEDICAL APPLICATION;

EID: 0041629526     PISSN: 00224456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Nakamura S, Structure of azomycin, a new antibiotic, Pharm Bull (Japan), 3 (1995) 379.
2. Cosar C & Julon L, Activite dep(hidrxy-2-ethyl)-1-methyl-3-nitro-5-imidazoles (8823 RP) vis-a-visdes, infections experimentales a Tricomonas vaginalis, Ann Inst Pasteur, 96 (1959) 238.
3. nd ed, edited by K Parfitt (Pharmaceutical Press, London) 1999, p. 585.
4. Kapoor V K & Mahindroo N, Chemical modifications of metronidazole, J Panjab Acad Sci, 1 (1999) 185.
5. Singh H & Kapoor V K, Medicinal and pharmaceutical chemistry (Vallabh Prakashan, Delhi) 1996, p. 419.
6. Jennings F W, Atouguia J M & Murray M, Topical chemotherapy for experimental murine African CNS-trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5-nitroimidazoles, fexinidazole or MK-436, Trop Med Inst Health, 1 (1996) 590.
7. Castelli M, Malagoli M, Lupo L, Roffia S, Paolucci F, Carmelli C, Zanca A & Baggio G, Cytotoxicity and probable mechanism of action of sulphimidazole, J Antimicrob Chemother, 46 (2000) 541.
8. Muller M, Reductive activation of nitroimidazoles in anaerobic microorganisms, Biochem Pharmacol, 35 (1986) 37.
9. Goldman P, Kotch R L, Yeung T, Chrystal E J T, Beaulieu, Jr., B B, McLafferty M A & Sudlow G, Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activities, Biochem Pharmacol, 35 (1986) 43.
10. Edwards D I, Reduction of nitroimidazoles in vitro and DNA damage, Biochem Pharmacol, 35 (1986) 53.
11. Mailiaros D P & Goldman P, Interaction of metronidazole with Escherichia coli deoxyribonucleic. acid, Biochem Pharmacol, 42 (1991) 1739.
12. Lau A H, Lam N P, Piscitelli S C, Wilkes L & Danziger L H, Clinical pharmacokinetics of metronidazole and other nitromidazoles, Clin Pharmacokinet, 23 (1992) 328.
13. Adams G E & Stratford I J, Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer, Biochem Pharmacol, 35 (1986) 71.
14. Stratford I J, O'Neill P, Sheldon P W, Silver A R J, Walling J M & Adams G E, RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions, Biochem Pharmacol, 35 (1986) 105.
15. Franko A J, Misonidazole and other hypoixa markers: metabolism and applications, Int J Radiat Oncol Biol Phy, 12 (1986) 1195.
16. Hodgkiss R J, Middleton R W, Parrick J, Rami H K, Wardman P & Wilson G D, Bioreductive fluorescent markers for hypoxic cells: a study of 2-nitroimidazoles with 1-substituents containing fluorescent, bridgehead - nitrogen, bicyclic systems, J Med Chem, 35 (1992) 1920.
17. McClain R M & Downing J C, The effect of ornidazole on fertility and epididymal sperm function in rats, Toxicol Appl Pharmacol, 92 (1988) 488.
18. Oberlander G, Yeung C H & Cooper T G, Induction of reversible infertility in male rats by oral ornidazole and its effects on sperm motility and epididymal secretions, J Reprod Fertil, 100 (1994) 551.
19. Yeung C H, Oberlander G & Cooper T G, Effects of the male antifertility agent ornidazole on sperm function in vitro and in the female genital tract, J Reprod Fertil, 103 (1996) 257.
20. Oberlander G, Yeung C H & Cooper T G, Influence of oral administration of ornidazole on capacitation and the activity of some glycolic enzymes of rat spermatozoa, J Reprod Fertil, 106 (1996) 231.
21. McClain R M, Downing J C & Edgcomb J E, Effect of metronidazole on fertility and testicular function in male rats, Fundament Appl Toxicol, 12 (1989) 386.
22. Cooper T G, Yeung C H, Skupin R & Haufe G, Antifertility potential of ornidazole analogues in rats, J Androl, 18 (1997) 431.
23. Agrawal K C, Bears K B, Sehgal R K, Brown N J, Rist P E & Rupp W D, Potential radiosensitizing agents, Dinitroimidazoles, J Med Chem, 22 (1979) 583.
24. Nagarajan K, Shankar, R G, Rajappa S, Shenoy, S J & Costa-Perira R, Nitroimidazoles XXI. 2,3-dihydro-6- nitroimidazo[2,1-b]oxazoles with antitubercular activity, Eur J Med Chem, 24 (1986) 631.
25. Walsh J S, Wang R, Bagan E, Wang C C, Wislock & Miwa G T, Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5- nitroimidazoles, J Med Chem, 30 (1987) 150.
26. Ashtekar D R, Costa-Perira R, Nagrajan K, Vishvanthan N, Bhatt A D & Rittel W, In vitro and in vivo activities of the nitroimidazole (GI-1734) against Mycobacterium tuberculosis, Antimicrob Agents Chemother, 37 (1993) 183.
27. Stover C K, Warrener P, VanDevanter D R, Sherrman D R, Arain R M, Langhome M H, Anderson S W, Towell J A, Yuan Y, AcMurray D N, Kreiswirth B N, Barry C E & Baker W R, A small molecule nitroimidazopyran drug candidate for the treatment of tuberculosis,